Atlas Trials

Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19

Clinical trial NCT04809974 · COMPLETED

Trial details

NCT number
NCT04809974
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Covid19Sequelae of; InfectionCognitive Symptom
Start date
2021-08-28
Primary completion
2023-10-05
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.